Figure 2.
Established and In-Development FLT3 inhibitors, dual inhibitors, and combination agents. Schematic detailing mechanisms of action of established and in-development FLT3 inhibitors, dual and multikinase inhibitors, and combination agents.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.